Review



mouse progranulin  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems mouse progranulin
    Mouse Progranulin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/10__1016_slash_j__isci__2026__115720-121-110-112
    Average 93 stars, based on 94 article reviews
    mouse progranulin - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Immunolabeling:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Clinical Proteomics:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Immunostaining:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    MANN-WHITNEY:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Activation Assay:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Expressing:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Plasmid Preparation:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Quantitative RT-PCR:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Amplification:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Agarose Gel Electrophoresis:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Two Tailed Test:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Marker:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Staining:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Transgenic Assay:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.

    Membrane:

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).

    Article Title: Reduction of Microglial Progranulin Does Not Exacerbate Pathology or Behavioral Deficits in Neuronal Progranulin-insufficient Mice
    Article Snippet: Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).Plasma (2µL) was diluted with LDS sample buffer (ThermoFisher) and Bolt sample reducing agent (ThermoFisher), and run on 4–12% Bis-Tris gels (ThermoFisher) before transferring to Immobilon-FL PVDF (MilliporeSigma).. Progranulin was detected with an anti-mouse progranulin antibody (R&D Systems #AF2557), followed by a biotinylated anti-sheep secondary antibody (Vector Laboratories) and IR-Dye 800-labelled streptavidin (LI-COR Biosciences).. Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).Amygdala Activation in a Novel, Social Environment Amygdala activation in a novel, social environment was conducted as previously described ( Scearce-Levie et al., 2008 ; Filiano et al., 2013 ).

    Article Title: Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model
    Article Snippet: The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).The primary antibodies employed were diluted in Dako Antibody Diluent (DakoCytomation).. The anti-mouse progranulin antibody (dilution 1∶70) was purchased from R&D systems, the anti-laminin antibody (dilution 1∶50) was purchased from Abcam, the anti-smooth muscle α-actin antibody (dilution 1∶100) and the anti-desmin (dilution 1∶100) were purchased from Dako; the anti-PECAM1 antibody (dilution 1∶25) was purchased from Santa Cruz and the VEGFR2 antibody (dilution 1∶600) was purchased from Cell Signaling.



    Similar Products

    mouse progranulin  (R&D Systems)
    93
    R&D Systems mouse progranulin
    Mouse Progranulin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/10__1016_slash_j__isci__2026__115720-121-110-112
    Average 93 stars, based on 1 article reviews
    mouse progranulin - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    pgrn  (R&D Systems)
    93
    R&D Systems pgrn
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Pgrn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/pmc12720004-210-44-48
    Average 93 stars, based on 1 article reviews
    pgrn - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    sheep antibody against pgrn  (R&D Systems)
    93
    R&D Systems sheep antibody against pgrn
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Sheep Antibody Against Pgrn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/pmc12720004-219-19-27
    Average 93 stars, based on 1 article reviews
    sheep antibody against pgrn - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    antimouse pgrn antibody  (R&D Systems)
    93
    R&D Systems antimouse pgrn antibody
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Antimouse Pgrn Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/10__1016_slash_j__apsb__2026__02__011-80-8-14
    Average 93 stars, based on 1 article reviews
    antimouse pgrn antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    antibodies against pgrn  (R&D Systems)
    93
    R&D Systems antibodies against pgrn
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Antibodies Against Pgrn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/10__1016_slash_j__apsb__2026__02__011-194-12-16
    Average 93 stars, based on 1 article reviews
    antibodies against pgrn - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    systems af2557 validation  (R&D Systems)
    93
    R&D Systems systems af2557 validation
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Systems Af2557 Validation, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/pm41606336-1054-76-75
    Average 93 stars, based on 1 article reviews
    systems af2557 validation - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    anti pgrn af2557  (R&D Systems)
    93
    R&D Systems anti pgrn af2557
    Increased protein levels <t>of</t> <t>PSAP</t> and <t>PGRN</t> within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.
    Anti Pgrn Af2557, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+progranulin+antibody/Mouse+Progranulin%2FPGRN+Antibody/pmc12802303-207-24-27
    Average 93 stars, based on 1 article reviews
    anti pgrn af2557 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Increased protein levels of PSAP and PGRN within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Increased protein levels of PSAP and PGRN within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.

    Article Snippet: Membranes were blocked with 5 % nonfat milk in TBS-T (1 % Tween 20) overnight at 4 °C and incubated in the appropriate primary antibody in 3 % BSA in TBS-T for 2 h at room temperature shaking with PSAP (1:1,000, 10801-1-AP, Proteintech, USA), PGRN (1:1,000, AF 2557, R&D Systems, USA), and GAPDH (1:5000 60004-1-Ig, proteintech, USA).

    Techniques: Staining, Protein Extraction, Western Blot, Expressing, Comparison

    Increased PSAP and PGRN immunostaining in the SFO and its surrounding tissues in SAP-D −/− mice a) Double immunofluorescent staining of PSAP (red) and PGRN (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. The white dotted lines enclose the SFO. b ) enlarged white ⅰ-iv squares in a, as indicated. White arrowheads indicate co-staining with anti-PGRN and PSAP antibodies. Open arrowheads indicate staining with PGRN alone. Nuclei are labeled by DAPI (blue) staining. All scale bars, 20 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Increased PSAP and PGRN immunostaining in the SFO and its surrounding tissues in SAP-D −/− mice a) Double immunofluorescent staining of PSAP (red) and PGRN (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. The white dotted lines enclose the SFO. b ) enlarged white ⅰ-iv squares in a, as indicated. White arrowheads indicate co-staining with anti-PGRN and PSAP antibodies. Open arrowheads indicate staining with PGRN alone. Nuclei are labeled by DAPI (blue) staining. All scale bars, 20 μm.

    Article Snippet: Membranes were blocked with 5 % nonfat milk in TBS-T (1 % Tween 20) overnight at 4 °C and incubated in the appropriate primary antibody in 3 % BSA in TBS-T for 2 h at room temperature shaking with PSAP (1:1,000, 10801-1-AP, Proteintech, USA), PGRN (1:1,000, AF 2557, R&D Systems, USA), and GAPDH (1:5000 60004-1-Ig, proteintech, USA).

    Techniques: Immunostaining, Staining, Labeling

    Infiltration of CD68-positive activated microglia/macrophages co-expressing PSAP and PGRN into the SFO and surrounding tissues a – b) Double immunofluorescent staining of PGRN (green) and CD68 (red) around the SFO in 10-month-old-female WT and SAP-D −/− mice. b , Magnified images of the indicated white squares in a . ⅰ: SFO, ⅱ: Fornix, and ⅲ: Perivascular, bv: blood vessel. c ) Quantification of PGRN- and/or CD68-staining in the SFO and surrounding areas in WT and SAP-D −/− mice. Data are shown as the mean ± SD (n = 3). The left panel presents a stacked bar chart, whereas the right panel shows the individual data values in a bar chart format. d – h ) Triple immunofluorescent staining of PSAP (red), PGRN (green), and CD68 (cyan) around the SFO in 10-month-old-female SAP-D −/− mice. e) Magnified images of the indicated white squares in d) ⅳ: Boundary, ⅴ: Fornix, and ⅵ: Perivascular. White arrowheads indicate triple co-staining with PSAP, PGRN, and CD68. Open arrowheads indicate PGRN signals alone. Co-localization rates of CD68 positive areas in PSAP ( f ), PGRN ( g ), and PSAP-PGRN staining areas ( h ) around the SFO of SAP-D −/− mice, respectively. f-h ) The left panel presents a stacked bar chart, whereas the right panel presents the individual data values in a bar chart format. Data are shown as mean ± SD (n = 3). Nuclei are labeled by DAPI (blue) staining. All scale bars, 50 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Infiltration of CD68-positive activated microglia/macrophages co-expressing PSAP and PGRN into the SFO and surrounding tissues a – b) Double immunofluorescent staining of PGRN (green) and CD68 (red) around the SFO in 10-month-old-female WT and SAP-D −/− mice. b , Magnified images of the indicated white squares in a . ⅰ: SFO, ⅱ: Fornix, and ⅲ: Perivascular, bv: blood vessel. c ) Quantification of PGRN- and/or CD68-staining in the SFO and surrounding areas in WT and SAP-D −/− mice. Data are shown as the mean ± SD (n = 3). The left panel presents a stacked bar chart, whereas the right panel shows the individual data values in a bar chart format. d – h ) Triple immunofluorescent staining of PSAP (red), PGRN (green), and CD68 (cyan) around the SFO in 10-month-old-female SAP-D −/− mice. e) Magnified images of the indicated white squares in d) ⅳ: Boundary, ⅴ: Fornix, and ⅵ: Perivascular. White arrowheads indicate triple co-staining with PSAP, PGRN, and CD68. Open arrowheads indicate PGRN signals alone. Co-localization rates of CD68 positive areas in PSAP ( f ), PGRN ( g ), and PSAP-PGRN staining areas ( h ) around the SFO of SAP-D −/− mice, respectively. f-h ) The left panel presents a stacked bar chart, whereas the right panel presents the individual data values in a bar chart format. Data are shown as mean ± SD (n = 3). Nuclei are labeled by DAPI (blue) staining. All scale bars, 50 μm.

    Article Snippet: Membranes were blocked with 5 % nonfat milk in TBS-T (1 % Tween 20) overnight at 4 °C and incubated in the appropriate primary antibody in 3 % BSA in TBS-T for 2 h at room temperature shaking with PSAP (1:1,000, 10801-1-AP, Proteintech, USA), PGRN (1:1,000, AF 2557, R&D Systems, USA), and GAPDH (1:5000 60004-1-Ig, proteintech, USA).

    Techniques: Expressing, Staining, Labeling

    Lysosomal localization of PSAP and PGRN expression around the SFO a) Immunofluorescence staining of LAMP1 (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. Nuclei are labeled by DAPI (blue) staining. b) Quantification of LAMP1-stained areas in ( a ) relative to WT (%). The results of Student's t-tests for each panel are as follows: left panel, p = 0.0059, Cohen's d = 2.35 (95 % CI: 15.89, 67.66); and right panel: p = 0.0061, Cohen's d = 2.33 (95 % CI: 51.06, 220.89). Data are shown as the mean ± SD (n = 5). c) Triple immunofluorescent staining of PSAP (red), PGRN (green), and LAMP1 (cyan) around the SFO of 10-month-old female SAP-D −/− mice. Enlarged images indicated by the white squares (ⅰ-iv) were shown in c. d) Localization rate of PGRN or PSAP to LAMP1 in the SFO. The results of Student's t-tests for each panel are as follows: left panel, p = 0.0008, Cohen's d = 2.24 (95 % CI: -40.90, -13.73); and right panel, p = 0.2341, Cohen's d = 0.64 (95 % CI: 26.80, 7.17). Data are shown as the mean ± SD (n = 6 for WT-SFO and n = 8 for SAP-D −/− -SFO). e) Same experiment as in (c) on microglia/macrophage co-expressing PSAP and PGRN, or PGRN only, in the boundary and fornix regions of SAP-D −/− mice. Single image for each antibody was shown in white, while double or triple merged images were presented with red (PSAP or PGRN), green (LAMP1 or PGRN), or cyan (LAMP1) as indicated. and indicate the individual values in each group (b and d). ns: no significant difference. ∗∗∗ p < 0.001. ∗∗ p < 0.01. All scale bars, 10 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Lysosomal localization of PSAP and PGRN expression around the SFO a) Immunofluorescence staining of LAMP1 (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. Nuclei are labeled by DAPI (blue) staining. b) Quantification of LAMP1-stained areas in ( a ) relative to WT (%). The results of Student's t-tests for each panel are as follows: left panel, p = 0.0059, Cohen's d = 2.35 (95 % CI: 15.89, 67.66); and right panel: p = 0.0061, Cohen's d = 2.33 (95 % CI: 51.06, 220.89). Data are shown as the mean ± SD (n = 5). c) Triple immunofluorescent staining of PSAP (red), PGRN (green), and LAMP1 (cyan) around the SFO of 10-month-old female SAP-D −/− mice. Enlarged images indicated by the white squares (ⅰ-iv) were shown in c. d) Localization rate of PGRN or PSAP to LAMP1 in the SFO. The results of Student's t-tests for each panel are as follows: left panel, p = 0.0008, Cohen's d = 2.24 (95 % CI: -40.90, -13.73); and right panel, p = 0.2341, Cohen's d = 0.64 (95 % CI: 26.80, 7.17). Data are shown as the mean ± SD (n = 6 for WT-SFO and n = 8 for SAP-D −/− -SFO). e) Same experiment as in (c) on microglia/macrophage co-expressing PSAP and PGRN, or PGRN only, in the boundary and fornix regions of SAP-D −/− mice. Single image for each antibody was shown in white, while double or triple merged images were presented with red (PSAP or PGRN), green (LAMP1 or PGRN), or cyan (LAMP1) as indicated. and indicate the individual values in each group (b and d). ns: no significant difference. ∗∗∗ p < 0.001. ∗∗ p < 0.01. All scale bars, 10 μm.

    Article Snippet: Membranes were blocked with 5 % nonfat milk in TBS-T (1 % Tween 20) overnight at 4 °C and incubated in the appropriate primary antibody in 3 % BSA in TBS-T for 2 h at room temperature shaking with PSAP (1:1,000, 10801-1-AP, Proteintech, USA), PGRN (1:1,000, AF 2557, R&D Systems, USA), and GAPDH (1:5000 60004-1-Ig, proteintech, USA).

    Techniques: Expressing, Immunofluorescence, Staining, Labeling

    Increased protein levels of PSAP and PGRN within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Increased protein levels of PSAP and PGRN within the SFO of SAP-D −/− mice a – b) , Coronal brain section at 0.7–0.8 mm posterior to bregma containing the SFO. a: DAPI staining. a-2: Enlarged view of the white square in a-1. SFO: subfornical organ, 3V: third ventricle. b; Double immunofluorescent staining of PSAP (red) and PGRN (green) in 10-month-old female WT and SAP-D −/− mice. DAPI (blue) staining showed the nuclei ( a and b ). Scale bar, 500 μm ( a and b ). White arrowheads indicate the SFO regions ( b ). c) Cerebral region from 3-, 6-, and 10-month-old male and female mice containing the SFO (0.7–0.8 mm posterior to ∗bregma) used for protein extraction and Western blot ( d – h ) using anti- PSAP, PGRN, and GAPDH antibodies. Quantification normalized to GAPDH expression and represented as the mean ± SD of three mice for each group. and indicate the individual values in each group ( e , f , h ). d – f) PSAP and PGRN protein levels in the SFO were remarkably increased. Their quantification by densitometric analysis is represented in e for male and f for female, respectively. e ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effects of genotype (F(1,24) = 547.7, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.51, −62.43]), with no effect of age ( p = 0.46) or genotype × age interaction ( p = 0.47). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 354.2, p < 0.0001, ηp 2 = 0.48, 95 % CI [−46.39, −37.22]), with no effect of age ( p = 0.73) or genotype × age interaction ( p = 0.76). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.87, 95 % CI [−52.71, −28.91]), 6 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−52.82, −29.02]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−52.32, −28.52]). f ) For PSAP/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 611.1, p < 0.0001, ηp 2 = 0.48, 95 % CI [−74.42, −62.95]), with no effect of age ( p = 0.07) or genotype × age interaction (p = 0.07). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 9.99, 95 % CI [−86.30, −54.96]), 6 M ( p < 0.0001, Cohen's d = 7.24, 95 % CI [−79.04, −47.70]), and 10 M ( p < 0.0001, Cohen's d = 8.77, 95 % CI [−87.09, −55.75]). For PGRN/GAPDH, two-way ANOVA revealed a significant main effect of genotype (F(1,24) = 273.5, p < 0.0001, ηp 2 = 0.47, 95 % CI [−63.96, −49.76]), with no effect of age ( p = 0.71) or genotype × age interaction (p = 0.70). Post-hoc Tukey's tests showed that SAP-D −/− differed from WT at 3 M ( p < 0.0001, Cohen's d = 7.31, 95 % CI [−73.43, −36.60]), 6 M ( p < 0.0001, Cohen's d = 5.71, 95 % CI [−73.04, −36.22]), and 10 M ( p < 0.0001, Cohen's d = 5.35, 95 % CI [−73.08, −36.26]). g – h ) Comparison of PSAP and PGRN protein expression in the SFO, whole cerebrum, and cerebellum. The quantitative analysis is shown in h . h ) For PSAP/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 30.06, p = 0.0007, η 2 = 0.90), but not in WT mice ( p = 0.3461). Tukey's post hoc tests showed significant differences for SFO versus cerebellum ( p = 0.0010, Cohen's d = 5.26, 95 % CI [46.80, 119.1]) as well as and cerebrum versus cerebellum ( p = 0.0018, Cohen's d = 9.34, 95 % CI [38.39, 110.6]). There was no significant difference for SFO versus cerebrum ( p = 0.76, Cohen's d = 0.47, 95 % CI [−27.71, 44.54]). For PGRN/GAPDH, one-way ANOVA revealed a significant effect in SAP-D −/− mice (F(2,6) = 54.42, p = 0.0001, η 2 = 0.94), but not in WT mice ( p = 0.6327). Tukey's post hoc tests showed significant differences for SFO versus cerebrum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]) as well as and SFO versus cerebellum ( p = 0.0005, Cohen's d = 5.43, 95 % CI [26.19, 57.84]), but not for cerebrum versus cerebellum ( p = 0.3274, Cohen's d = 6.06, 95 % CI [−7.72, 23.92]). ns: no significant difference. ∗∗∗∗ p < 0.0001. ∗∗∗ p < 0.001. ∗∗ p < 0.01.

    Article Snippet: The primary antibodies used were a rabbit antibody against PSAP (dilution 1:100, 10801-1-AP, Proteintech Group Inc., IL, USA), a sheep antibody against PGRN (dilution 1:100, AF 2557, R&D Systems Inc., MN, USA), a guinea pig antibody against c-Fos (dilution 1:500, 226308, Synaptic Systems GmbH, Göttingen, Germany), a rat antibody against CD68-FITC conjugated (dilution 1:500, MCA1957FA, BIO-RAD Laboratories Inc., CA, USA), and a rat antibody against LAMP1 (dilution 1:100, ab25245, Abcam, Cambridge, UK).

    Techniques: Staining, Protein Extraction, Western Blot, Expressing, Comparison

    Increased PSAP and PGRN immunostaining in the SFO and its surrounding tissues in SAP-D −/− mice a) Double immunofluorescent staining of PSAP (red) and PGRN (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. The white dotted lines enclose the SFO. b ) enlarged white ⅰ-iv squares in a, as indicated. White arrowheads indicate co-staining with anti-PGRN and PSAP antibodies. Open arrowheads indicate staining with PGRN alone. Nuclei are labeled by DAPI (blue) staining. All scale bars, 20 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Increased PSAP and PGRN immunostaining in the SFO and its surrounding tissues in SAP-D −/− mice a) Double immunofluorescent staining of PSAP (red) and PGRN (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. The white dotted lines enclose the SFO. b ) enlarged white ⅰ-iv squares in a, as indicated. White arrowheads indicate co-staining with anti-PGRN and PSAP antibodies. Open arrowheads indicate staining with PGRN alone. Nuclei are labeled by DAPI (blue) staining. All scale bars, 20 μm.

    Article Snippet: The primary antibodies used were a rabbit antibody against PSAP (dilution 1:100, 10801-1-AP, Proteintech Group Inc., IL, USA), a sheep antibody against PGRN (dilution 1:100, AF 2557, R&D Systems Inc., MN, USA), a guinea pig antibody against c-Fos (dilution 1:500, 226308, Synaptic Systems GmbH, Göttingen, Germany), a rat antibody against CD68-FITC conjugated (dilution 1:500, MCA1957FA, BIO-RAD Laboratories Inc., CA, USA), and a rat antibody against LAMP1 (dilution 1:100, ab25245, Abcam, Cambridge, UK).

    Techniques: Immunostaining, Staining, Labeling

    Infiltration of CD68-positive activated microglia/macrophages co-expressing PSAP and PGRN into the SFO and surrounding tissues a – b) Double immunofluorescent staining of PGRN (green) and CD68 (red) around the SFO in 10-month-old-female WT and SAP-D −/− mice. b , Magnified images of the indicated white squares in a . ⅰ: SFO, ⅱ: Fornix, and ⅲ: Perivascular, bv: blood vessel. c ) Quantification of PGRN- and/or CD68-staining in the SFO and surrounding areas in WT and SAP-D −/− mice. Data are shown as the mean ± SD (n = 3). The left panel presents a stacked bar chart, whereas the right panel shows the individual data values in a bar chart format. d – h ) Triple immunofluorescent staining of PSAP (red), PGRN (green), and CD68 (cyan) around the SFO in 10-month-old-female SAP-D −/− mice. e) Magnified images of the indicated white squares in d) ⅳ: Boundary, ⅴ: Fornix, and ⅵ: Perivascular. White arrowheads indicate triple co-staining with PSAP, PGRN, and CD68. Open arrowheads indicate PGRN signals alone. Co-localization rates of CD68 positive areas in PSAP ( f ), PGRN ( g ), and PSAP-PGRN staining areas ( h ) around the SFO of SAP-D −/− mice, respectively. f-h ) The left panel presents a stacked bar chart, whereas the right panel presents the individual data values in a bar chart format. Data are shown as mean ± SD (n = 3). Nuclei are labeled by DAPI (blue) staining. All scale bars, 50 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Infiltration of CD68-positive activated microglia/macrophages co-expressing PSAP and PGRN into the SFO and surrounding tissues a – b) Double immunofluorescent staining of PGRN (green) and CD68 (red) around the SFO in 10-month-old-female WT and SAP-D −/− mice. b , Magnified images of the indicated white squares in a . ⅰ: SFO, ⅱ: Fornix, and ⅲ: Perivascular, bv: blood vessel. c ) Quantification of PGRN- and/or CD68-staining in the SFO and surrounding areas in WT and SAP-D −/− mice. Data are shown as the mean ± SD (n = 3). The left panel presents a stacked bar chart, whereas the right panel shows the individual data values in a bar chart format. d – h ) Triple immunofluorescent staining of PSAP (red), PGRN (green), and CD68 (cyan) around the SFO in 10-month-old-female SAP-D −/− mice. e) Magnified images of the indicated white squares in d) ⅳ: Boundary, ⅴ: Fornix, and ⅵ: Perivascular. White arrowheads indicate triple co-staining with PSAP, PGRN, and CD68. Open arrowheads indicate PGRN signals alone. Co-localization rates of CD68 positive areas in PSAP ( f ), PGRN ( g ), and PSAP-PGRN staining areas ( h ) around the SFO of SAP-D −/− mice, respectively. f-h ) The left panel presents a stacked bar chart, whereas the right panel presents the individual data values in a bar chart format. Data are shown as mean ± SD (n = 3). Nuclei are labeled by DAPI (blue) staining. All scale bars, 50 μm.

    Article Snippet: The primary antibodies used were a rabbit antibody against PSAP (dilution 1:100, 10801-1-AP, Proteintech Group Inc., IL, USA), a sheep antibody against PGRN (dilution 1:100, AF 2557, R&D Systems Inc., MN, USA), a guinea pig antibody against c-Fos (dilution 1:500, 226308, Synaptic Systems GmbH, Göttingen, Germany), a rat antibody against CD68-FITC conjugated (dilution 1:500, MCA1957FA, BIO-RAD Laboratories Inc., CA, USA), and a rat antibody against LAMP1 (dilution 1:100, ab25245, Abcam, Cambridge, UK).

    Techniques: Expressing, Staining, Labeling

    Lysosomal localization of PSAP and PGRN expression around the SFO a) Immunofluorescence staining of LAMP1 (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. Nuclei are labeled by DAPI (blue) staining. b) Quantification of LAMP1-stained areas in ( a ) relative to WT (%). The results of Student's t-tests for each panel are as follows: left panel, p = 0.0059, Cohen's d = 2.35 (95 % CI: 15.89, 67.66); and right panel: p = 0.0061, Cohen's d = 2.33 (95 % CI: 51.06, 220.89). Data are shown as the mean ± SD (n = 5). c) Triple immunofluorescent staining of PSAP (red), PGRN (green), and LAMP1 (cyan) around the SFO of 10-month-old female SAP-D −/− mice. Enlarged images indicated by the white squares (ⅰ-iv) were shown in c. d) Localization rate of PGRN or PSAP to LAMP1 in the SFO. The results of Student's t-tests for each panel are as follows: left panel, p = 0.0008, Cohen's d = 2.24 (95 % CI: -40.90, -13.73); and right panel, p = 0.2341, Cohen's d = 0.64 (95 % CI: 26.80, 7.17). Data are shown as the mean ± SD (n = 6 for WT-SFO and n = 8 for SAP-D −/− -SFO). e) Same experiment as in (c) on microglia/macrophage co-expressing PSAP and PGRN, or PGRN only, in the boundary and fornix regions of SAP-D −/− mice. Single image for each antibody was shown in white, while double or triple merged images were presented with red (PSAP or PGRN), green (LAMP1 or PGRN), or cyan (LAMP1) as indicated. and indicate the individual values in each group (b and d). ns: no significant difference. ∗∗∗ p < 0.001. ∗∗ p < 0.01. All scale bars, 10 μm.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Accumulation of prosaposin and progranulin around the subfornical organ induces polydipsia in SAP-D-deficient mice

    doi: 10.1016/j.bbrep.2025.102388

    Figure Lengend Snippet: Lysosomal localization of PSAP and PGRN expression around the SFO a) Immunofluorescence staining of LAMP1 (green) around the SFO in 10-month-old female WT and SAP-D −/− mice. Nuclei are labeled by DAPI (blue) staining. b) Quantification of LAMP1-stained areas in ( a ) relative to WT (%). The results of Student's t-tests for each panel are as follows: left panel, p = 0.0059, Cohen's d = 2.35 (95 % CI: 15.89, 67.66); and right panel: p = 0.0061, Cohen's d = 2.33 (95 % CI: 51.06, 220.89). Data are shown as the mean ± SD (n = 5). c) Triple immunofluorescent staining of PSAP (red), PGRN (green), and LAMP1 (cyan) around the SFO of 10-month-old female SAP-D −/− mice. Enlarged images indicated by the white squares (ⅰ-iv) were shown in c. d) Localization rate of PGRN or PSAP to LAMP1 in the SFO. The results of Student's t-tests for each panel are as follows: left panel, p = 0.0008, Cohen's d = 2.24 (95 % CI: -40.90, -13.73); and right panel, p = 0.2341, Cohen's d = 0.64 (95 % CI: 26.80, 7.17). Data are shown as the mean ± SD (n = 6 for WT-SFO and n = 8 for SAP-D −/− -SFO). e) Same experiment as in (c) on microglia/macrophage co-expressing PSAP and PGRN, or PGRN only, in the boundary and fornix regions of SAP-D −/− mice. Single image for each antibody was shown in white, while double or triple merged images were presented with red (PSAP or PGRN), green (LAMP1 or PGRN), or cyan (LAMP1) as indicated. and indicate the individual values in each group (b and d). ns: no significant difference. ∗∗∗ p < 0.001. ∗∗ p < 0.01. All scale bars, 10 μm.

    Article Snippet: The primary antibodies used were a rabbit antibody against PSAP (dilution 1:100, 10801-1-AP, Proteintech Group Inc., IL, USA), a sheep antibody against PGRN (dilution 1:100, AF 2557, R&D Systems Inc., MN, USA), a guinea pig antibody against c-Fos (dilution 1:500, 226308, Synaptic Systems GmbH, Göttingen, Germany), a rat antibody against CD68-FITC conjugated (dilution 1:500, MCA1957FA, BIO-RAD Laboratories Inc., CA, USA), and a rat antibody against LAMP1 (dilution 1:100, ab25245, Abcam, Cambridge, UK).

    Techniques: Expressing, Immunofluorescence, Staining, Labeling